Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,177,967 papers from all fields of science
Search
Sign In
Create Free Account
Gemcitabine-Cisplatin Regimen
Known as:
gemcitabine/cisplatin regimen
A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer, advanced bladder cancer, advanced cervical…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Carcinoma of bladder
Cervical Adenocarcinoma
Cisplatin
Epithelial ovarian cancer
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Recent advances in medical therapy for metastatic urothelial cancer
T. Yuasa
,
S. Urakami
,
J. Yonese
International Journal of Clinical Oncology
2018
Corpus ID: 4004035
Cytotoxic chemotherapy has been the mainstay of medical therapy for metastatic urothelial cancer. Currently, the gemcitabine…
Expand
2018
2018
Influence of different drug delivery methods for Endostar combined with a gemcitabine/cisplatin regimen in locally advanced or metastatic lung squamous cell carcinoma
Difei Yao
,
Hong Shen
,
Jian-jin Huang
,
Ying Yuan
,
Haibin Dai
Medicine
2018
Corpus ID: 51953002
Abstract Continuous endovenous administration of Endostar (CE) gradually replaced drip intravenous administration of Endostar (DE…
Expand
2013
2013
Docetaxel as second line after failure of gemcitabine/cisplatin regimen in advanced and/or metastatic urinary bladder cancer patients in Egypt
E. Elkholy
,
M. E. E. Din
2013
Corpus ID: 80354182
There were an estimated 72.570 new cases and 15.210 deaths from bladder cancer in 2013. It represents 4.4% of all new cancer…
Expand
2006
2006
A trial of gemcitabine (gems) in combination with cisplatin for treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC).
M. Yang
,
H. Wang
,
W. Wang
,
T. Chiou
,
P. Chen
Journal of Clinical Oncology
2006
Corpus ID: 41559799
15505 Aims: To determine the efficacy of gemcitabine in combination with cisplatin, and to assess the safety profile of the…
Expand
2005
2005
[A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer].
Li Zhang
,
Ning Li
,
Fei Xu
,
Yang Zhang
Zhongguo fei ai za zhi = Chinese journal of lung…
2005
Corpus ID: 11624207
BACKGROUND Although platinum-based chemotherapy has become a standard treatment for non-small cell lung cancer (NSCLC), its…
Expand
2004
2004
Gemcitabine and Cisplatin following Surgical Treatment of Urinary Bladder Carcinosarcoma
R. Damiano
,
M. D'armiento
,
+4 authors
S. Venuta
Tumori
2004
Corpus ID: 6560258
The clinical case of a 73-year-old man with a history of transitional cell carcinoma of the bladder, an ulcerated mass on the…
Expand
2004
2004
A non-intensive gemcitabine-cisplatin regimen in pancreatic cancer significantly improves quality of life and pharmacoeconomics with high response rates.
A. Waterston
,
A. Glasgow
,
A. Thiliginayam
,
R. Williamson
,
H. Wasan
Journal of Clinical Oncology
2004
Corpus ID: 23498794
8155 AIM: This Prospective Phase II study was undertaken to determine whether a dose-modified gemcitabine-cisplatin regimen…
Expand
Highly Cited
2002
Highly Cited
2002
Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine
J. Bellmunt
,
J. Albanell
,
+8 authors
J. Baselga
Cancer
2002
Corpus ID: 20908027
New chemotherapeutic agents, including paclitaxel and gemcitabine, are active in advanced bladder carcinoma, and combination…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE